Efficacy of new oral anticoagulants in patients with atrial fibrillation previously treated with warfarin: a meta-analysis of randomized controlled trials

Int J Cardiol. 2014 Apr 15;173(1):122-4. doi: 10.1016/j.ijcard.2014.02.027. Epub 2014 Feb 22.

Authors

Laurent Fauchier¹, Nicolas Clementy², Christophe Saint-Etienne², Edouard Simeon², Denis Angoulvant², Anne Bernard-Brunet²

Affiliations

¹ Cardiologie, Pole Cœur Thorax Vasculaire, Centre Hospitalier Universitaire Trousseau, et Faculté de Médecine, Université Francois Rabelais, Tours, France. Electronic address: lfau@med.univ-tours.fr.
² Cardiologie, Pole Cœur Thorax Vasculaire, Centre Hospitalier Universitaire Trousseau, et Faculté de Médecine, Université Francois Rabelais, Tours, France.

PMID: 24636544
DOI: 10.1016/j.ijcard.2014.02.027

No abstract available

Keywords: Apixaban; Atrial fibrillation; Dabigatran; Rivaroxaban; Stroke; Warfarin.

Publication types

Letter
Meta-Analysis

MeSH terms

Administration, Oral
Anticoagulants / administration & dosage*
Anticoagulants / adverse effects
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / mortality
Hemorrhage / chemically induced
Hemorrhage / mortality
Humans
Randomized Controlled Trials as Topic* / mortality
Treatment Outcome
Warfarin / administration & dosage*
Warfarin / adverse effects

Substances

Anticoagulants
Warfarin